These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21514481)

  • 21. Policy implications of oral agents.
    Spoelstra SL; Given BA; Given CW; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):161-5. PubMed ID: 21514485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are patients on oral chemotherapy in your practice setting safe?
    Moody M; Jackowski J
    Clin J Oncol Nurs; 2010 Jun; 14(3):339-46. PubMed ID: 20529795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges of oral medications in patients with advanced breast cancer.
    Palmieri FM; Barton DL
    Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S17-22. PubMed ID: 18054678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How can healthcare providers ensure patients adhere to oral therapies?
    ONS Connect; 2014 Mar; 29(1):27. PubMed ID: 24669530
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral cancer chemotherapy: the promise and the pitfalls.
    McLeod HL; Evans WE
    Clin Cancer Res; 1999 Oct; 5(10):2669-71. PubMed ID: 10537326
    [No Abstract]   [Full Text] [Related]  

  • 27. Age span challenges: adherence in pediatric oncology.
    Landier W
    Semin Oncol Nurs; 2011 May; 27(2):142-53. PubMed ID: 21514483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Adherence to therapy with oral antineoplastic agents.
    de Lemos M
    J Natl Cancer Inst; 2002 Nov; 94(21):1652; author reply 1652. PubMed ID: 12419795
    [No Abstract]   [Full Text] [Related]  

  • 29. No ordinary pill.
    Merenda C
    ONS Connect; 2014 Mar; 29(1):22-6. PubMed ID: 24669529
    [No Abstract]   [Full Text] [Related]  

  • 30. Improving adherence to oral anticancer therapy.
    Davey MP
    Nursing; 2013 Sep; 43(9):31-6. PubMed ID: 23963388
    [No Abstract]   [Full Text] [Related]  

  • 31. Nursing strategies for patients on oral chemotherapy.
    Hollywood E; Semple D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):37-9; discussion 40. PubMed ID: 11219976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term oral administration of anticancer drug (author's transl)].
    Soejima S
    Nihon Gan Chiryo Gakkai Shi; 1979 Dec; 14(7):1136-45. PubMed ID: 120403
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes.
    Macintosh PW; Pond GR; Pond BJ; Leung V; Siu LL
    Eur J Cancer Care (Engl); 2007 Jul; 16(4):380-6. PubMed ID: 17587364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in chemotherapy. Administration and nursing implications.
    Cawley MM
    Nurs Clin North Am; 1990 Jun; 25(2):377-91. PubMed ID: 2186387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.
    Klein CE; Kastrissios H; Miller AA; Hollis D; Yu D; Rosner GL; Grinblatt DL; Larson RA; Ratain MJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):199-206. PubMed ID: 16158312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A survey of compliance to oral anti-cancer drugs in outpatients].
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):485-8. PubMed ID: 22616127
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient selection for oral chemotherapy.
    Sharma S
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):33-5. PubMed ID: 11219975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence influencing factors in patients taking oral anticancer agents: a systematic review.
    Mathes T; Pieper D; Antoine SL; Eikermann M
    Cancer Epidemiol; 2014 Jun; 38(3):214-26. PubMed ID: 24768601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difficult to swallow: issues affecting optimal adherence to oral anticancer agents.
    Cheung WY
    Am Soc Clin Oncol Educ Book; 2013; ():265-70. PubMed ID: 23714519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.